Table of Content

1 Study Coverage
1.1 Minimal Residual Disease (MRD) Testing Product Introduction
1.2 Global Minimal Residual Disease (MRD) Testing Outlook 2018 VS 2022 VS 2033
1.2.1 Global Minimal Residual Disease (MRD) Testing Market Size for the Year 2018-2033
1.2.2 United States Minimal Residual Disease (MRD) Testing Market Size for the Year 2018-2033
1.3 Minimal Residual Disease (MRD) Testing Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Minimal Residual Disease (MRD) Testing in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Minimal Residual Disease (MRD) Testing Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Minimal Residual Disease (MRD) Testing Market Dynamics
1.4.1 Minimal Residual Disease (MRD) Testing Industry Trends
1.4.2 Minimal Residual Disease (MRD) Testing Market Drivers
1.4.3 Minimal Residual Disease (MRD) Testing Market Challenges
1.4.4 Minimal Residual Disease (MRD) Testing Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Minimal Residual Disease (MRD) Testing by Type
2.1 Minimal Residual Disease (MRD) Testing Market Segment by Type
2.1.1 Flow Cytometry
2.1.2 Polymerase Chain Reaction
2.1.3 Next-generation Sequencing
2.1.4 Liquid Biopsies
2.2 Global Minimal Residual Disease (MRD) Testing Market Size by Type (2018, 2022 & 2033)
2.3 Global Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2033)
2.4 United States Minimal Residual Disease (MRD) Testing Market Size by Type (2018, 2022 & 2033)
2.5 United States Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2033)
3 Minimal Residual Disease (MRD) Testing by Application
3.1 Minimal Residual Disease (MRD) Testing Market Segment by Application
3.1.1 Specialty Clinics
3.1.2 Hospitals
3.1.3 Research Institutions
3.2 Global Minimal Residual Disease (MRD) Testing Market Size by Application (2018, 2022 & 2033)
3.3 Global Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2033)
3.4 United States Minimal Residual Disease (MRD) Testing Market Size by Application (2018, 2022 & 2033)
3.5 United States Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2033)
4 Global Minimal Residual Disease (MRD) Testing Competitor Landscape by Company
4.1 Global Minimal Residual Disease (MRD) Testing Market Size by Company
4.1.1 Global Key Companies of Minimal Residual Disease (MRD) Testing, Ranked by Revenue (2022)
4.1.2 Global Minimal Residual Disease (MRD) Testing Revenue by Player (2018-2023)
4.2 Global Minimal Residual Disease (MRD) Testing Concentration Ratio (CR)
4.2.1 Minimal Residual Disease (MRD) Testing Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Minimal Residual Disease (MRD) Testing in 2022
4.2.3 Global Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Minimal Residual Disease (MRD) Testing Head office and Area Served
4.4 Global Key Players of Minimal Residual Disease (MRD) Testing, Product and Application
4.5 Global Key Players of Minimal Residual Disease (MRD) Testing, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Minimal Residual Disease (MRD) Testing Market Size by Company
4.7.1 Key Players of Minimal Residual Disease (MRD) Testing in United States, Ranked by Revenue (2022)
4.7.2 United States Minimal Residual Disease (MRD) Testing Revenue by Players (2021, 2022 & 2023)
5 Global Minimal Residual Disease (MRD) Testing Market Size by Region
5.1 Global Minimal Residual Disease (MRD) Testing Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2033)
5.2.1 Global Minimal Residual Disease (MRD) Testing Market Size by Region: 2018-2023
5.2.2 Global Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033)
6 Americas
6.1 Americas Minimal Residual Disease (MRD) Testing Market Size YoY Growth 2018-2033
6.2 Americas Minimal Residual Disease (MRD) Testing Market Size by Type
6.2.1 Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
6.2.2 Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
6.2.3 Americas Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
6.3 Americas Minimal Residual Disease (MRD) Testing Market Size by Application
6.3.1 Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
6.3.2 Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
6.3.3 Americas Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
6.4 Americas Minimal Residual Disease (MRD) Testing Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Minimal Residual Disease (MRD) Testing Market Size YoY Growth 2018-2033
7.2 EMEA Minimal Residual Disease (MRD) Testing Market Size by Type
7.2.1 EMEA Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
7.2.2 EMEA Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
7.2.3 EMEA Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
7.3 EMEA Minimal Residual Disease (MRD) Testing Market Size by Application
7.3.1 EMEA Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
7.3.2 EMEA Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
7.3.3 EMEA Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
7.4 EMEA Minimal Residual Disease (MRD) Testing Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Minimal Residual Disease (MRD) Testing Market Size YoY Growth 2018-2033
8.2 China Minimal Residual Disease (MRD) Testing Market Size by Type
8.2.1 China Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
8.2.2 China Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
8.2.3 China Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
8.3 China Minimal Residual Disease (MRD) Testing Market Size by Application
8.3.1 China Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
8.3.2 China Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
8.3.3 China Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Minimal Residual Disease (MRD) Testing Market Size YoY Growth 2018-2033
9.2 APAC Minimal Residual Disease (MRD) Testing Market Size by Type
9.2.1 APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
9.2.2 APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033)
9.2.3 APAC Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
9.3 APAC Minimal Residual Disease (MRD) Testing Market Size by Application
9.3.1 APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
9.3.2 APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033)
9.3.3 APAC Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
9.4 APAC Minimal Residual Disease (MRD) Testing Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Sysmex Corporation
10.1.1 Sysmex Corporation Company Details
10.1.2 Sysmex Corporation Business Overview
10.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Introduction
10.1.4 Sysmex Corporation Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.1.5 Sysmex Corporation Recent Development
10.2 Natera
10.2.1 Natera Company Details
10.2.2 Natera Business Overview
10.2.3 Natera Minimal Residual Disease (MRD) Testing Introduction
10.2.4 Natera Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.2.5 Natera Recent Development
10.3 Asuragen
10.3.1 Asuragen Company Details
10.3.2 Asuragen Business Overview
10.3.3 Asuragen Minimal Residual Disease (MRD) Testing Introduction
10.3.4 Asuragen Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.3.5 Asuragen Recent Development
10.4 Quest Diagnostics
10.4.1 Quest Diagnostics Company Details
10.4.2 Quest Diagnostics Business Overview
10.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Introduction
10.4.4 Quest Diagnostics Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.4.5 Quest Diagnostics Recent Development
10.5 Mission Bio
10.5.1 Mission Bio Company Details
10.5.2 Mission Bio Business Overview
10.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Introduction
10.5.4 Mission Bio Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.5.5 Mission Bio Recent Development
10.6 LabCorp
10.6.1 LabCorp Company Details
10.6.2 LabCorp Business Overview
10.6.3 LabCorp Minimal Residual Disease (MRD) Testing Introduction
10.6.4 LabCorp Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.6.5 LabCorp Recent Development
10.7 Guardant Health
10.7.1 Guardant Health Company Details
10.7.2 Guardant Health Business Overview
10.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Introduction
10.7.4 Guardant Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.7.5 Guardant Health Recent Development
10.8 NeoGenomics Laboratories
10.8.1 NeoGenomics Laboratories Company Details
10.8.2 NeoGenomics Laboratories Business Overview
10.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Introduction
10.8.4 NeoGenomics Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.8.5 NeoGenomics Laboratories Recent Development
10.9 ARUP Laboratories
10.9.1 ARUP Laboratories Company Details
10.9.2 ARUP Laboratories Business Overview
10.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Introduction
10.9.4 ARUP Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.9.5 ARUP Laboratories Recent Development
10.10 NeoGenomics , Inc
10.10.1 NeoGenomics , Inc Company Details
10.10.2 NeoGenomics , Inc Business Overview
10.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Introduction
10.10.4 NeoGenomics , Inc Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.10.5 NeoGenomics , Inc Recent Development
10.11 Opko Health
10.11.1 Opko Health Company Details
10.11.2 Opko Health Business Overview
10.11.3 Opko Health Minimal Residual Disease (MRD) Testing Introduction
10.11.4 Opko Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.11.5 Opko Health Recent Development
10.12 Bio-Rad Laboratories
10.12.1 Bio-Rad Laboratories Company Details
10.12.2 Bio-Rad Laboratories Business Overview
10.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Introduction
10.12.4 Bio-Rad Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
10.12.5 Bio-Rad Laboratories Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Minimal Residual Disease (MRD) Testing Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Minimal Residual Disease (MRD) Testing Market Trends
Table 3. Minimal Residual Disease (MRD) Testing Market Drivers
Table 4. Minimal Residual Disease (MRD) Testing Market Challenges
Table 5. Minimal Residual Disease (MRD) Testing Market Restraints
Table 6. Global Minimal Residual Disease (MRD) Testing Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Minimal Residual Disease (MRD) Testing Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Minimal Residual Disease (MRD) Testing Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Minimal Residual Disease (MRD) Testing Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Minimal Residual Disease (MRD) Testing, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Minimal Residual Disease (MRD) Testing Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Minimal Residual Disease (MRD) Testing Revenue Share by Player, 2018-2023
Table 13. Global Minimal Residual Disease (MRD) Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Minimal Residual Disease (MRD) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Table 15. Global Key Players of Minimal Residual Disease (MRD) Testing, Headquarters and Area Served
Table 16. Global Key Players of Minimal Residual Disease (MRD) Testing, Product and Application
Table 17. Global Key Players of Minimal Residual Disease (MRD) Testing, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Minimal Residual Disease (MRD) Testing in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Minimal Residual Disease (MRD) Testing Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Minimal Residual Disease (MRD) Testing Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 51. Sysmex Corporation Company Details
Table 52. Sysmex Corporation Business Overview
Table 53. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product
Table 54. Sysmex Corporation Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 55. Sysmex Corporation Recent Development
Table 56. Natera Company Details
Table 57. Natera Business Overview
Table 58. Natera Minimal Residual Disease (MRD) Testing Product
Table 59. Natera Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 60. Natera Recent Development
Table 61. Asuragen Company Details
Table 62. Asuragen Business Overview
Table 63. Asuragen Minimal Residual Disease (MRD) Testing Product
Table 64. Asuragen Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 65. Asuragen Recent Development
Table 66. Quest Diagnostics Company Details
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product
Table 69. Quest Diagnostics Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 70. Quest Diagnostics Recent Development
Table 71. Mission Bio Company Details
Table 72. Mission Bio Business Overview
Table 73. Mission Bio Minimal Residual Disease (MRD) Testing Product
Table 74. Mission Bio Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 75. Mission Bio Recent Development
Table 76. LabCorp Company Details
Table 77. LabCorp Business Overview
Table 78. LabCorp Minimal Residual Disease (MRD) Testing Product
Table 79. LabCorp Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 80. LabCorp Recent Development
Table 81. Guardant Health Company Details
Table 82. Guardant Health Business Overview
Table 83. Guardant Health Minimal Residual Disease (MRD) Testing Product
Table 84. Guardant Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 85. Guardant Health Recent Development
Table 86. NeoGenomics Laboratories Company Details
Table 87. NeoGenomics Laboratories Business Overview
Table 88. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product
Table 89. NeoGenomics Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 90. NeoGenomics Laboratories Recent Development
Table 91. ARUP Laboratories Company Details
Table 92. ARUP Laboratories Business Overview
Table 93. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product
Table 94. ARUP Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 95. ARUP Laboratories Recent Development
Table 96. NeoGenomics , Inc Company Details
Table 97. NeoGenomics , Inc Business Overview
Table 98. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product
Table 99. NeoGenomics , Inc Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 100. NeoGenomics , Inc Recent Development
Table 101. Opko Health Company Details
Table 102. Opko Health Business Overview
Table 103. Opko Health Minimal Residual Disease (MRD) Testing Product
Table 104. Opko Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 105. Opko Health Recent Development
Table 106. Bio-Rad Laboratories Company Details
Table 107. Bio-Rad Laboratories Business Overview
Table 108. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product
Table 109. Bio-Rad Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 110. Bio-Rad Laboratories Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Minimal Residual Disease (MRD) Testing Product Picture
Figure 2. Global Minimal Residual Disease (MRD) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Minimal Residual Disease (MRD) Testing Market Size 2018-2033 (US$ Million)
Figure 4. United States Minimal Residual Disease (MRD) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Minimal Residual Disease (MRD) Testing Market Size 2018-2033 (US$ Million)
Figure 6. United States Minimal Residual Disease (MRD) Testing Market Share in Global 2018-2033
Figure 7. Minimal Residual Disease (MRD) Testing Report Years Considered
Figure 8. Product Picture of Flow Cytometry
Figure 9. Product Picture of Polymerase Chain Reaction
Figure 10. Product Picture of Next-generation Sequencing
Figure 11. Product Picture of Liquid Biopsies
Figure 12. Global Minimal Residual Disease (MRD) Testing Market Share by Type in 2022 & 2033
Figure 13. Global Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2033) & (US$ Million)
Figure 14. Global Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 15. United States Minimal Residual Disease (MRD) Testing Market Share by Type in 2022 & 2033
Figure 16. United States Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2033) & (US$ Million)
Figure 17. United States Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 18. Product Picture of Specialty Clinics
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Research Institutions
Figure 21. Global Minimal Residual Disease (MRD) Testing Market Share by Application in 2022 & 2033
Figure 22. Global Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2033) & (US$ Million)
Figure 23. Global Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 24. United States Minimal Residual Disease (MRD) Testing Market Share by Application in 2022 & 2033
Figure 25. United States Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2033) & (US$ Million)
Figure 26. United States Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 27. The Top 5 and 10 Largest Companies of Minimal Residual Disease (MRD) Testing in the World: Market Share by Minimal Residual Disease (MRD) Testing Revenue in 2022
Figure 28. Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 29. Global Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2033)
Figure 30. Americas Minimal Residual Disease (MRD) Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 31. Americas Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 32. Americas Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 33. United States Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Canada Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Mexico Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Brazil Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. EMEA Minimal Residual Disease (MRD) Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 38. EMEA Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 39. EMEA Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 40. Europe Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Middle East Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Africa Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Minimal Residual Disease (MRD) Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. China Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 45. China Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 46. APAC Minimal Residual Disease (MRD) Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. APAC Minimal Residual Disease (MRD) Testing Market Share by Type (2018-2033)
Figure 48. APAC Minimal Residual Disease (MRD) Testing Market Share by Application (2018-2033)
Figure 49. Japan Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. South Korea Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. China Taiwan Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. India Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. Sysmex Corporation Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 55. Natera Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 56. Asuragen Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 57. Quest Diagnostics Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 58. Mission Bio Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 59. LabCorp Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 60. Guardant Health Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 61. NeoGenomics Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 62. ARUP Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 63. NeoGenomics , Inc Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 64. Opko Health Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed